163 related articles for article (PubMed ID: 38313014)
1. Association between lactic acidosis and multiple organ dysfunction syndrome after cardiopulmonary bypass.
Zheng D; Yu GL; Zhou YP; Zhang QM; Wang CG; Zhang S
PeerJ; 2024; 12():e16769. PubMed ID: 38313014
[TBL] [Abstract][Full Text] [Related]
2. Risk Factors and Consequences of Late-Onset Hyperlactatemia After Cardiac Surgery With Cardiopulmonary Bypass: A Single-Center Retrospective Study.
Aubourg C; Collard A; Léger M; Gros A; Fouquet O; Sargentini C; Rineau E
J Cardiothorac Vasc Anesth; 2022 Nov; 36(11):4077-4084. PubMed ID: 36028378
[TBL] [Abstract][Full Text] [Related]
3. Hemodilution on cardiopulmonary bypass as a determinant of early postoperative hyperlactatemia.
Ranucci M; Carboni G; Cotza M; Bianchi P; Di Dedda U; Aloisio T;
PLoS One; 2015; 10(5):e0126939. PubMed ID: 25992896
[TBL] [Abstract][Full Text] [Related]
4. Associations between oxygen delivery and cardiac index with hyperlactatemia during cardiopulmonary bypass.
Condello I; Santarpino G; Nasso G; Moscarelli M; Fiore F; Speziale G
JTCVS Tech; 2020 Jun; 2():92-99. PubMed ID: 34317766
[TBL] [Abstract][Full Text] [Related]
5. Effects of norepinephrine infusion during cardiopulmonary bypass on perioperative changes in lactic acid level (Norcal).
Khalil MA; El Tahan MR; Khidr AM; Fallatah S; Abohamar AD; Amer MM; Makhdom F; El Ghoneimy Y; Al Bassam B; Alghamdi T; Abdulfattah D
Perfusion; 2023 Nov; 38(8):1584-1599. PubMed ID: 35994013
[TBL] [Abstract][Full Text] [Related]
6. Hyperlactatemia in patients undergoing adult cardiac surgery under cardiopulmonary bypass: Causative factors and its effect on surgical outcome.
Naik R; George G; Karuppiah S; Philip MA
Ann Card Anaesth; 2016; 19(4):668-675. PubMed ID: 27716698
[TBL] [Abstract][Full Text] [Related]
7. Risk factors of post-operative severe hyperlactatemia and lactic acidosis following laparoscopic resection for pheochromocytoma.
Wu S; Chen W; Shen L; Xu L; Zhu A; Huang Y
Sci Rep; 2017 Mar; 7(1):403. PubMed ID: 28341846
[TBL] [Abstract][Full Text] [Related]
8. The Association Between Hypophosphatemia and Lactic Acidosis After Cardiac Surgery With Cardiopulmonary Bypass: A Retrospective Cohort Study.
Steck DT; Jelacic S; Mostofi N; Wu D; Wells L; Fong CT; Cain KC; Sheu RD; Togashi K
J Cardiothorac Vasc Anesth; 2023 Mar; 37(3):374-381. PubMed ID: 36528501
[TBL] [Abstract][Full Text] [Related]
9. Cholinesterase level is a predictor of systemic inflammatory response syndrome and complications after cardiopulmonary bypass.
Yang Y; Yang X; Yang J
Ann Palliat Med; 2021 Nov; 10(11):11714-11720. PubMed ID: 34872296
[TBL] [Abstract][Full Text] [Related]
10. Intestinal fatty acid-binding protein as a predictor of prognosis in postoperative cardiac surgery patients.
Zou L; Song X; Hong L; Shen X; Sun J; Zhang C; Mu X
Medicine (Baltimore); 2018 Aug; 97(33):e11782. PubMed ID: 30113465
[TBL] [Abstract][Full Text] [Related]
11. Low Microcirculatory Perfused Vessel Density and High Heterogeneity are Associated With Increased Intensity and Duration of Lactic Acidosis After Cardiac Surgery with Cardiopulmonary Bypass.
Greenwood JC; Jang DH; Spelde AE; Gutsche JT; Horak J; Acker MA; Kilbaugh TJ; Shofer FS; Augoustides JGT; Bakker J; Abella BS
Shock; 2021 Aug; 56(2):245-254. PubMed ID: 33394972
[TBL] [Abstract][Full Text] [Related]
12. What factors are associated with hyperlactatemia after cardiac surgery characterized by well-maintained oxygen delivery and a normal postoperative course? A retrospective study.
Inoue S; Kuro M; Furuya H
Eur J Anaesthesiol; 2001 Sep; 18(9):576-84. PubMed ID: 11553252
[TBL] [Abstract][Full Text] [Related]
13. Type B lactic acidosis following cardiopulmonary bypass.
Raper RF; Cameron G; Walker D; Bowey CJ
Crit Care Med; 1997 Jan; 25(1):46-51. PubMed ID: 8989175
[TBL] [Abstract][Full Text] [Related]
14. Sufentanil: a risk factor for lactic acidosis in patients after heart valve surgery.
Zhan YF; Shi Q; Pan YC; Zheng BS; Ge YP; Luo TG; Xiao ZH; Jiang W
J Cardiothorac Surg; 2022 Sep; 17(1):233. PubMed ID: 36085208
[TBL] [Abstract][Full Text] [Related]
15. Circulating inflammatory mediators and organ dysfunction after cardiovascular surgery with cardiopulmonary bypass: a prospective observational study.
de Mendonça-Filho HT; Pereira KC; Fontes M; Vieira DA; de Mendonça ML; Campos LA; Castro-Faria-Neto HC
Crit Care; 2006; 10(2):R46. PubMed ID: 16542504
[TBL] [Abstract][Full Text] [Related]
16. Biomarker-based risk model to predict persistent multiple organ dysfunctions after congenital heart surgery: a prospective observational cohort study.
Benscoter AL; Alten JA; Atreya MR; Cooper DS; Byrnes JW; Nelson DP; Ollberding NJ; Wong HR
Crit Care; 2023 May; 27(1):193. PubMed ID: 37210541
[TBL] [Abstract][Full Text] [Related]
17. [CLINICAL ASPECTS OF THE BLOOD LACTATE DYNAMICS DURING OPERATIONS ON THE HEART AND THE AORTA IN CONDITIONS OF CARDIOPULMONARY BYPASS.].
Trekova NA; Akselrod BA; Yudichev II; Gus'kov DA; Markin AV; Popov AM
Anesteziol Reanimatol; 2016 Sep; 61(5):324-329. PubMed ID: 29489096
[TBL] [Abstract][Full Text] [Related]
18. Comparison of ringer's lactate and plasmalyt-a as cardiopulmonary bypass prime for bypass associated acidosis in valve replacement surgeries.
Surabhi S; Kumar M
Ann Card Anaesth; 2021; 24(1):36-41. PubMed ID: 33938829
[TBL] [Abstract][Full Text] [Related]
19. ΔPCO
Zhang S; Zheng D; Chu XQ; Jiang YP; Wang CG; Zhang QM; Qian LZ; Yang WY; Zhang WY; Tung TH; Lin RH
Front Cardiovasc Med; 2021; 8():759826. PubMed ID: 34926611
[No Abstract] [Full Text] [Related]
20. The Incidence, Risk Factors, and Outcomes of Hyperlactatemia after Heart Transplantation.
Hoshino Y; Kinoshita O; Ono M
Int Heart J; 2018 Jan; 59(1):81-86. PubMed ID: 29279533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
